0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biopharmaceutical Excipient Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-31N13926
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Excipient Manufacturing Market Research Report 2023
BUY CHAPTERS

Biopharmaceutical Excipient Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31N13926
Report
October 2024
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical Excipient Manufacturing - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical Excipient Manufacturing - Market

Biopharmaceutical Excipient Manufacturing - Market

The global market for Biopharmaceutical Excipient Manufacturing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Excipient Manufacturing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Excipient Manufacturing by region & country, by Type, and by Application.
The Biopharmaceutical Excipient Manufacturing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Excipient Manufacturing.
Market Segmentation

Scope of Biopharmaceutical Excipient Manufacturing - Market Report

Report Metric Details
Report Name Biopharmaceutical Excipient Manufacturing - Market
CAGR 5%
Segment by Type:
  • Polymers
  • Solubilizers/Surfactants
  • Polyols
  • Proteins/Amino Acids
  • Others
Segment by Application
  • Biotechnology
  • Pharmaceutical Company
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abitec, Avantor, Basf Pharma, Corden Pharma, Dfe Pharma, Evonik, Kirsch Pharma, Merck Kgaa, Pfanstiehl, Roquette, Spectrum Chemical Manufacturing, Spi Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biopharmaceutical Excipient Manufacturing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biopharmaceutical Excipient Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biopharmaceutical Excipient Manufacturing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Biopharmaceutical Excipient Manufacturing - Market report?

Ans: The main players in the Biopharmaceutical Excipient Manufacturing - Market are Abitec, Avantor, Basf Pharma, Corden Pharma, Dfe Pharma, Evonik, Kirsch Pharma, Merck Kgaa, Pfanstiehl, Roquette, Spectrum Chemical Manufacturing, Spi Pharma

What are the Application segmentation covered in the Biopharmaceutical Excipient Manufacturing - Market report?

Ans: The Applications covered in the Biopharmaceutical Excipient Manufacturing - Market report are Biotechnology, Pharmaceutical Company, Others

What are the Type segmentation covered in the Biopharmaceutical Excipient Manufacturing - Market report?

Ans: The Types covered in the Biopharmaceutical Excipient Manufacturing - Market report are Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids, Others

1 Market Overview
1.1 Biopharmaceutical Excipient Manufacturing Product Introduction
1.2 Global Biopharmaceutical Excipient Manufacturing Market Size Forecast
1.3 Biopharmaceutical Excipient Manufacturing Market Trends & Drivers
1.3.1 Biopharmaceutical Excipient Manufacturing Industry Trends
1.3.2 Biopharmaceutical Excipient Manufacturing Market Drivers & Opportunity
1.3.3 Biopharmaceutical Excipient Manufacturing Market Challenges
1.3.4 Biopharmaceutical Excipient Manufacturing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Excipient Manufacturing Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Excipient Manufacturing Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Excipient Manufacturing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Excipient Manufacturing Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Excipient Manufacturing
2.6 Biopharmaceutical Excipient Manufacturing Market Competitive Analysis
2.6.1 Biopharmaceutical Excipient Manufacturing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Excipient Manufacturing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Excipient Manufacturing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polymers
3.1.2 Solubilizers/Surfactants
3.1.3 Polyols
3.1.4 Proteins/Amino Acids
3.1.5 Others
3.2 Global Biopharmaceutical Excipient Manufacturing Sales Value by Type
3.2.1 Global Biopharmaceutical Excipient Manufacturing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Excipient Manufacturing Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Excipient Manufacturing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology
4.1.2 Pharmaceutical Company
4.1.3 Others
4.2 Global Biopharmaceutical Excipient Manufacturing Sales Value by Application
4.2.1 Global Biopharmaceutical Excipient Manufacturing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Excipient Manufacturing Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Excipient Manufacturing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Excipient Manufacturing Sales Value by Region
5.1.1 Global Biopharmaceutical Excipient Manufacturing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Excipient Manufacturing Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Excipient Manufacturing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abitec
7.1.1 Abitec Profile
7.1.2 Abitec Main Business
7.1.3 Abitec Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.1.4 Abitec Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.1.5 Abitec Recent Developments
7.2 Avantor
7.2.1 Avantor Profile
7.2.2 Avantor Main Business
7.2.3 Avantor Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.2.4 Avantor Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.2.5 Avantor Recent Developments
7.3 Basf Pharma
7.3.1 Basf Pharma Profile
7.3.2 Basf Pharma Main Business
7.3.3 Basf Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.3.4 Basf Pharma Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.3.5 Corden Pharma Recent Developments
7.4 Corden Pharma
7.4.1 Corden Pharma Profile
7.4.2 Corden Pharma Main Business
7.4.3 Corden Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.4.4 Corden Pharma Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.4.5 Corden Pharma Recent Developments
7.5 Dfe Pharma
7.5.1 Dfe Pharma Profile
7.5.2 Dfe Pharma Main Business
7.5.3 Dfe Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.5.4 Dfe Pharma Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.5.5 Dfe Pharma Recent Developments
7.6 Evonik
7.6.1 Evonik Profile
7.6.2 Evonik Main Business
7.6.3 Evonik Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.6.4 Evonik Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.6.5 Evonik Recent Developments
7.7 Kirsch Pharma
7.7.1 Kirsch Pharma Profile
7.7.2 Kirsch Pharma Main Business
7.7.3 Kirsch Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.7.4 Kirsch Pharma Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.7.5 Kirsch Pharma Recent Developments
7.8 Merck Kgaa
7.8.1 Merck Kgaa Profile
7.8.2 Merck Kgaa Main Business
7.8.3 Merck Kgaa Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.8.4 Merck Kgaa Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.8.5 Merck Kgaa Recent Developments
7.9 Pfanstiehl
7.9.1 Pfanstiehl Profile
7.9.2 Pfanstiehl Main Business
7.9.3 Pfanstiehl Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.9.4 Pfanstiehl Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.9.5 Pfanstiehl Recent Developments
7.10 Roquette
7.10.1 Roquette Profile
7.10.2 Roquette Main Business
7.10.3 Roquette Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.10.4 Roquette Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.10.5 Roquette Recent Developments
7.11 Spectrum Chemical Manufacturing
7.11.1 Spectrum Chemical Manufacturing Profile
7.11.2 Spectrum Chemical Manufacturing Main Business
7.11.3 Spectrum Chemical Manufacturing Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.11.4 Spectrum Chemical Manufacturing Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.11.5 Spectrum Chemical Manufacturing Recent Developments
7.12 Spi Pharma
7.12.1 Spi Pharma Profile
7.12.2 Spi Pharma Main Business
7.12.3 Spi Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
7.12.4 Spi Pharma Biopharmaceutical Excipient Manufacturing Revenue (US$ Million) & (2019-2024)
7.12.5 Spi Pharma Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Excipient Manufacturing Industrial Chain
8.2 Biopharmaceutical Excipient Manufacturing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Excipient Manufacturing Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Excipient Manufacturing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biopharmaceutical Excipient Manufacturing Market Trends
    Table 2. Biopharmaceutical Excipient Manufacturing Market Drivers & Opportunity
    Table 3. Biopharmaceutical Excipient Manufacturing Market Challenges
    Table 4. Biopharmaceutical Excipient Manufacturing Market Restraints
    Table 5. Global Biopharmaceutical Excipient Manufacturing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biopharmaceutical Excipient Manufacturing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biopharmaceutical Excipient Manufacturing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biopharmaceutical Excipient Manufacturing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Excipient Manufacturing
    Table 10. Global Biopharmaceutical Excipient Manufacturing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Excipient Manufacturing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biopharmaceutical Excipient Manufacturing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biopharmaceutical Excipient Manufacturing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biopharmaceutical Excipient Manufacturing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biopharmaceutical Excipient Manufacturing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biopharmaceutical Excipient Manufacturing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biopharmaceutical Excipient Manufacturing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biopharmaceutical Excipient Manufacturing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biopharmaceutical Excipient Manufacturing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biopharmaceutical Excipient Manufacturing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biopharmaceutical Excipient Manufacturing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biopharmaceutical Excipient Manufacturing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biopharmaceutical Excipient Manufacturing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abitec Basic Information List
    Table 32. Abitec Description and Business Overview
    Table 33. Abitec Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Abitec (2019-2024)
    Table 35. Abitec Recent Developments
    Table 36. Avantor Basic Information List
    Table 37. Avantor Description and Business Overview
    Table 38. Avantor Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Avantor (2019-2024)
    Table 40. Avantor Recent Developments
    Table 41. Basf Pharma Basic Information List
    Table 42. Basf Pharma Description and Business Overview
    Table 43. Basf Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Basf Pharma (2019-2024)
    Table 45. Basf Pharma Recent Developments
    Table 46. Corden Pharma Basic Information List
    Table 47. Corden Pharma Description and Business Overview
    Table 48. Corden Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Corden Pharma (2019-2024)
    Table 50. Corden Pharma Recent Developments
    Table 51. Dfe Pharma Basic Information List
    Table 52. Dfe Pharma Description and Business Overview
    Table 53. Dfe Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Dfe Pharma (2019-2024)
    Table 55. Dfe Pharma Recent Developments
    Table 56. Evonik Basic Information List
    Table 57. Evonik Description and Business Overview
    Table 58. Evonik Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Evonik (2019-2024)
    Table 60. Evonik Recent Developments
    Table 61. Kirsch Pharma Basic Information List
    Table 62. Kirsch Pharma Description and Business Overview
    Table 63. Kirsch Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Kirsch Pharma (2019-2024)
    Table 65. Kirsch Pharma Recent Developments
    Table 66. Merck Kgaa Basic Information List
    Table 67. Merck Kgaa Description and Business Overview
    Table 68. Merck Kgaa Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Merck Kgaa (2019-2024)
    Table 70. Merck Kgaa Recent Developments
    Table 71. Pfanstiehl Basic Information List
    Table 72. Pfanstiehl Description and Business Overview
    Table 73. Pfanstiehl Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Pfanstiehl (2019-2024)
    Table 75. Pfanstiehl Recent Developments
    Table 76. Roquette Basic Information List
    Table 77. Roquette Description and Business Overview
    Table 78. Roquette Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Roquette (2019-2024)
    Table 80. Roquette Recent Developments
    Table 81. Spectrum Chemical Manufacturing Basic Information List
    Table 82. Spectrum Chemical Manufacturing Description and Business Overview
    Table 83. Spectrum Chemical Manufacturing Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Spectrum Chemical Manufacturing (2019-2024)
    Table 85. Spectrum Chemical Manufacturing Recent Developments
    Table 86. Spi Pharma Basic Information List
    Table 87. Spi Pharma Description and Business Overview
    Table 88. Spi Pharma Biopharmaceutical Excipient Manufacturing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Biopharmaceutical Excipient Manufacturing Business of Spi Pharma (2019-2024)
    Table 90. Spi Pharma Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Biopharmaceutical Excipient Manufacturing Downstream Customers
    Table 94. Biopharmaceutical Excipient Manufacturing Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biopharmaceutical Excipient Manufacturing Product Picture
    Figure 2. Global Biopharmaceutical Excipient Manufacturing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biopharmaceutical Excipient Manufacturing Report Years Considered
    Figure 5. Global Biopharmaceutical Excipient Manufacturing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Excipient Manufacturing Revenue in 2023
    Figure 7. Biopharmaceutical Excipient Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Polymers Picture
    Figure 9. Solubilizers/Surfactants Picture
    Figure 10. Polyols Picture
    Figure 11. Proteins/Amino Acids Picture
    Figure 12. Others Picture
    Figure 13. Global Biopharmaceutical Excipient Manufacturing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Biopharmaceutical Excipient Manufacturing Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Biotechnology
    Figure 16. Product Picture of Pharmaceutical Company
    Figure 17. Product Picture of Others
    Figure 18. Global Biopharmaceutical Excipient Manufacturing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Biopharmaceutical Excipient Manufacturing Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Biopharmaceutical Excipient Manufacturing Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Biopharmaceutical Excipient Manufacturing Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Biopharmaceutical Excipient Manufacturing Sales Value (%), (2019-2030)
    Figure 31. United States Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Biopharmaceutical Excipient Manufacturing Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Biopharmaceutical Excipient Manufacturing Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Biopharmaceutical Excipient Manufacturing Sales Value by Application (%), 2023 VS 2030
    Figure 52. Biopharmaceutical Excipient Manufacturing Industrial Chain
    Figure 53. Biopharmaceutical Excipient Manufacturing Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Packaging of Effervescent Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-17Q10023
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-8U10163
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11I9951
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-34H832
Fri Dec 27 00:00:00 UTC 2024

Add to Cart